Tumor progression and recurrence after direct-acting antiviral therapy for hepatitis C in patients with previously treated or active hepatocellular carcinoma

被引：0
|
作者：
Wong, M. Y. W. [1 ]
Mccaughan, G. W. [1 ]
Mason, S. [1 ]
Moore, B. [1 ]
Koorey, D. J. [1 ]
Bowen, D. G. [1 ]
Strasser, S. I. [1 ]
机构：
[1] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：77 / 78
页数：2
相关论文
共 50 条
  • [21] Interaction Between Hepatocellular Carcinoma and Hepatitis C Eradication With Direct-acting Antiviral Therapy
    Venkata Rajesh Konjeti
    Binu V. John
    Current Treatment Options in Gastroenterology, 2018, 16 (2) : 203 - 214
  • [22] Impact of direct-acting antiviral therapy for hepatitis C-related hepatocellular carcinoma
    Lin, Wei-Chen
    Lin, Yang-Sheng
    Chang, Chen-Wang
    Chang, Ching-Wei
    Wang, Tsang-En
    Wang, Horng-Yuan
    Chen, Ming-Jen
    PLOS ONE, 2020, 15 (05):
  • [23] Hepatocellular Carcinoma Occurrence and Recurrence in Hepatitis C-infected Patients Treated with Direct-acting Antivirals
    Syed, Taseen
    Fazili, Javid
    Ali, Ijlal Akbar
    Zhao, Daniel
    Hughes, Diane
    Mahmood, Sultan
    CUREUS, 2018, 10 (06):
  • [24] Direct-Acting Antiviral Therapy for Hepatitis C Virus in Patients with BCLC Stage B/C Hepatocellular Carcinoma
    Lee, Shou-Wu
    Chen, Li-Shu
    Yang, Sheng-Shun
    Huang, Yi-Hsiang
    Lee, Teng-Yu
    VIRUSES-BASEL, 2022, 14 (11):
  • [25] Hepatocellular carcinoma recurrence after direct-acting antiviral therapy for hepatitis C virus. A systematic review and meta-analysis.
    Frazzoni, Leonardo
    Sikandar, Usama
    Metelli, Flavio
    Sadalla, Sinan
    Mazzella, Giuseppe
    Bazzoli, Franco
    Fuccio, Lorenzo
    Azzaroli, Francesco
    JOURNAL OF HEPATOLOGY, 2021, 75 : S518 - S518
  • [26] Risk of hepatocellular carcinoma among patients with hepatitis C virus cirrhosis treated with direct-acting antiviral therapy: An Australian experience
    Snell, J.
    Hong, T.
    Glasgow, S.
    Papaluca, T.
    New, K.
    Mcclure, T.
    Bell, S.
    Demeduik, B.
    Jeremiah, C.
    Tran, S.
    Phan, D.
    Jarman, M.
    Iser, D.
    Lust, M.
    Shaw, G.
    Desmond, P.
    Croagh, C.
    Visvanathan, K.
    Howell, J.
    Ryan, M.
    Thompson, A. J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 80 - 81
  • [27] Hepatocellular Carcinoma Occurrence in Non-Cirrhotic Hepatitis C Patients Treated With Direct-Acting Antiviral Agents
    Hejab, Amal
    Ramo, Aula
    Greib, Bradley
    Mansour, Jonathan
    Salgia, Reena
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1592 - S1592
  • [28] Hepatocellular carcinoma after direct-acting antiviral therapy in kidney transplant recipients infected with hepatitis C virus
    Calca, Rita
    Jorge, Cristina
    Lebre, Luis
    Cacheira, Eunice
    Querido, Sara
    Nascimento, Celia
    Adragao, Teresa
    Bruges, Margarida
    Weigert, Andre
    Machado, Domingos
    NEFROLOGIA, 2020, 40 (06): : 675 - 676
  • [29] Risk for Hepatocellular Carcinoma After Hepatitis C Virus Antiviral Therapy With Direct-Acting Antivirals: Case Closed?
    Maan, Raoel
    Feld, Jordan J.
    GASTROENTEROLOGY, 2017, 153 (04) : 890 - 892
  • [30] Is there increased risk of hepatocellular carcinoma recurrence in liver transplant patients with direct-acting antiviral therapy?
    Ashokkumar Jain
    Danielle Miller
    Ian Schreibman
    Thomas R. Riley
    Karen L. Krok
    Takehiko Dohi
    Rajeev Sharma
    Zakiyah Kadry
    Hepatology International, 2019, 13 : 190 - 198
12345